Anna Schuh, MD, PhD, FRCP, FRCPath

Director of Molecular Diagnostics (Oxford Molecular Diagnostic Centre), Professor of Molecular Diagnostics (Department of Oncology)
Oxford Molecular Diagnostic Centre, Department of Oncology, University of Oxford
Oxford, United Kingdom

Anna Schuh, MD, PhD, FRCP, FRCPath
Professor of Molecular Diagnostics
Department of Oncology, University of Oxford
Interest in CLL genomics
Principle Investigator of >50 early/late phase clinical trials in CLL
Led the UK clinical trial collaborative group for 4 years
Board member of the iwCLL where she chairs the Global Partnership Subcommittee
Directs Oxford Master Programme in Global Precision Cancer Medicine
Co-founder of SerenOx, a social enterprise to improve access to diagnostics in Africa.

Presentation(s):

• (1551637) T cell type abundance and gene expression patterns in the context of clinical progression of treatment-naïve CLL/MBL patients from the OxPLoreD study

  Friday, October 6, 2023
  11:20 AM – 11:25 AM EDT

• YIM Keynote

  Friday, October 6, 2023
  2:20 PM – 2:50 PM EDT

• (1552406) Sequencing of circulating tumour DNA reveals additional driver mutations in Richter Transformation

  Monday, October 9, 2023
  9:05 AM – 9:10 AM EDT

• Session 10: Global Perspective on CLL Management - Real World Data and Patient Experiences

  Monday, October 9, 2023
  1:55 PM – 3:25 PM EDT

• Special Announcement from the iwCLL

  Monday, October 9, 2023
  1:55 PM – 2:00 PM EDT